Formpipe Preliminary Q4: High Costs Hurting Margins - Redeye
Redeye comments on the preliminary Q4 figures from Formpipe. While hurting Q4 2024, the implications for 2025 and onwards are likely minor. However, the important ACV/ARR figures are not yet disclosed.
ANNONS
Redeye comments on the preliminary Q4 figures from Formpipe. While hurting Q4 2024, the implications for 2025 and onwards are likely minor. However, the important ACV/ARR figures are not yet disclosed.
